Delivery Order SPE2DB22D1017-SPE2DB25FF5PF
Award Date
2/14/25
Potential Completion Date
3/10/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.23 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm-fixed-price contract is for the supply of the drug VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of February 3, 2025. The award is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract has a June 20, 2024 ultimate completion date and was awarded on May 29, 2024. This contract award is not designated under any set-aside program. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $12,960.30 firm-fixed price delivery order is for the supply of 4,565,825,583 units of the drug product VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of October 7, 2024 and there was no set-aside used. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of January 8, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF8RH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the medical product VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of May 20, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product, with a ceiling value of $12,960.30 and a performance period ending on May 29, 2024. The contract is a delivery order that is priced on a firm fixed price basis. It is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 delivery order contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S. This is a firm fixed-price delivery order contract with a completion date of December 19, 2024. The contract was awarded on November 27, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...